GB1219606A
(en)
|
1968-07-15 |
1971-01-20 |
Rech S Et D Applic Scient Soge |
Quinuclidinol derivatives and preparation thereof
|
US4091218A
(en)
*
|
1975-12-29 |
1978-05-23 |
Texaco Development Corporation |
Morpholine process
|
EP0147716A3
(de)
|
1983-12-24 |
1987-10-28 |
ANT Nachrichtentechnik GmbH |
Verfahren und Anordnung zur verschlüsselbaren Übertragung einer Nachrichten-Binärzeichenfolge mit Authentizitätsprüfung
|
JPS6235216A
(ja)
|
1985-08-09 |
1987-02-16 |
Noritoshi Nakabachi |
不均質物質層の層厚非破壊測定方法および装置
|
GB8916480D0
(en)
|
1989-07-19 |
1989-09-06 |
Glaxo Group Ltd |
Chemical process
|
GB8923590D0
(en)
|
1989-10-19 |
1989-12-06 |
Pfizer Ltd |
Antimuscarinic bronchodilators
|
US5648370A
(en)
*
|
1990-11-20 |
1997-07-15 |
Astra Pharmaceuticals Limited |
7-(2-aminoethyl) benzothiazolones
|
GB9211172D0
(en)
|
1992-05-27 |
1992-07-08 |
Fisons Plc |
Compounds
|
PT100441A
(pt)
|
1991-05-02 |
1993-09-30 |
Smithkline Beecham Corp |
Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso
|
US5451700A
(en)
|
1991-06-11 |
1995-09-19 |
Ciba-Geigy Corporation |
Amidino compounds, their manufacture and methods of treatment
|
JPH0525045A
(ja)
|
1991-07-18 |
1993-02-02 |
Tanabe Seiyaku Co Ltd |
経皮吸収製剤
|
WO1993018007A1
(en)
|
1992-03-13 |
1993-09-16 |
Tokyo Tanabe Company Limited |
Novel carbostyril derivative
|
AU677776B2
(en)
|
1992-04-02 |
1997-05-08 |
Smithkline Beecham Corporation |
Compounds useful for treating allergic and inflammatory diseases
|
WO1993019750A1
(en)
|
1992-04-02 |
1993-10-14 |
Smithkline Beecham Corporation |
Compounds useful for treating allergic or inflammatory diseases
|
WO1993019751A1
(en)
|
1992-04-02 |
1993-10-14 |
Smithkline Beecham Corporation |
Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor
|
GB9301000D0
(en)
|
1993-01-20 |
1993-03-10 |
Glaxo Group Ltd |
Chemical compounds
|
CA2167287A1
(en)
|
1993-07-16 |
1995-01-26 |
George Joseph Quallich |
Enantioselective process for thiazole intermediates
|
GB9414208D0
(en)
|
1994-07-14 |
1994-08-31 |
Glaxo Group Ltd |
Compounds
|
GB9414193D0
(en)
|
1994-07-14 |
1994-08-31 |
Glaxo Group Ltd |
Compounds
|
PT807101E
(pt)
|
1995-02-01 |
2001-12-28 |
Upjohn Co |
2-aminoindanos comoligandos selectivos de dopamina d3
|
TW356468B
(en)
|
1995-09-15 |
1999-04-21 |
Astra Pharma Prod |
Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same
|
GB9622386D0
(en)
|
1996-10-28 |
1997-01-08 |
Sandoz Ltd |
Organic compounds
|
TW528755B
(en)
|
1996-12-24 |
2003-04-21 |
Glaxo Group Ltd |
2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
|
WO1999009018A1
(fr)
*
|
1997-08-14 |
1999-02-25 |
Kirin Beer Kabushiki Kaisha |
DERIVES DE BENZOTHIAZOLONE PRESENTANT UNE ACTIVITE SELECTIVE D'AGONISTE DU RECEPTEUR β2
|
US6166037A
(en)
|
1997-08-28 |
2000-12-26 |
Merck & Co., Inc. |
Pyrrolidine and piperidine modulators of chemokine receptor activity
|
WO1999016766A1
(fr)
|
1997-10-01 |
1999-04-08 |
Kyowa Hakko Kogyo Co., Ltd. |
Derives de benzodioxole
|
GB9723566D0
(en)
|
1997-11-08 |
1998-01-07 |
Glaxo Group Ltd |
Chemical compounds
|
GB9723590D0
(en)
|
1997-11-08 |
1998-01-07 |
Glaxo Group Ltd |
Chemical compounds
|
GB9723589D0
(en)
|
1997-11-08 |
1998-01-07 |
Glaxo Group Ltd |
Chemical compounds
|
WO1999036095A1
(en)
|
1998-01-13 |
1999-07-22 |
Astrazeneca Uk Limited |
PHARMACEUTICAL COMPOSITIONS COMPRISING A COMPOUND HAVING DOPAMINE (D2) RECEPTOR AGONIST ACTIVITY AND A COMPOUND (B) HAVING β2-ADRENORECEPTOR AGONIST ACTIVITY
|
YU44900A
(sh)
|
1998-01-31 |
2003-01-31 |
Glaxo Group Limited |
Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
|
AR017457A1
(es)
|
1998-02-14 |
2001-09-05 |
Glaxo Group Ltd |
Compuestos derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol, procesos para su preparacion, composiciones que los contienen y su uso en terapia para el tratamiento de enfermedades inflamatorias.
|
US6362371B1
(en)
|
1998-06-08 |
2002-03-26 |
Advanced Medicine, Inc. |
β2- adrenergic receptor agonists
|
AU750462B2
(en)
|
1998-06-23 |
2002-07-18 |
Glaxo Group Limited |
2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
|
GB9813535D0
(en)
|
1998-06-23 |
1998-08-19 |
Glaxo Group Ltd |
Chemical compounds
|
GB9813565D0
(en)
|
1998-06-23 |
1998-08-19 |
Glaxo Group Ltd |
Chemical compounds
|
GB9813540D0
(en)
|
1998-06-23 |
1998-08-19 |
Glaxo Group Ltd |
Chemical compounds
|
CN1146616C
(zh)
|
1998-06-30 |
2004-04-21 |
陶氏环球技术公司 |
聚合物多元醇及其生产方法
|
AU5879299A
(en)
|
1998-10-16 |
2000-05-08 |
Monaghan, Sandra Marina |
Adenine derivatives
|
GB9913083D0
(en)
|
1999-06-04 |
1999-08-04 |
Novartis Ag |
Organic compounds
|
JP3722700B2
(ja)
|
1999-05-04 |
2005-11-30 |
シェーリング コーポレイション |
Ccr5アンタゴニストとして有用なピペラジン誘導体
|
ES2246233T3
(es)
|
1999-05-04 |
2006-02-16 |
Schering Corporation |
Derivados de piperidina utiles como antagonistas de ccr5.
|
YU25500A
(sh)
|
1999-05-11 |
2003-08-29 |
Pfizer Products Inc. |
Postupak za sintezu analoga nukleozida
|
US6683115B2
(en)
|
1999-06-02 |
2004-01-27 |
Theravance, Inc. |
β2-adrenergic receptor agonists
|
GB9913932D0
(en)
|
1999-06-15 |
1999-08-18 |
Pfizer Ltd |
Purine derivatives
|
US6322771B1
(en)
|
1999-06-18 |
2001-11-27 |
University Of Virginia Patent Foundation |
Induction of pharmacological stress with adenosine receptor agonists
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
TR200201317T2
(tr)
|
1999-08-21 |
2002-11-21 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Sinerjistik kombinasyon.
|
CO5180581A1
(es)
|
1999-09-30 |
2002-07-30 |
Pfizer Prod Inc |
Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia
|
GB9924361D0
(en)
|
1999-10-14 |
1999-12-15 |
Pfizer Ltd |
Purine derivatives
|
GB9924363D0
(en)
|
1999-10-14 |
1999-12-15 |
Pfizer Central Res |
Purine derivatives
|
OA11558A
(en)
|
1999-12-08 |
2004-06-03 |
Advanced Medicine Inc |
Beta 2-adrenergic receptor agonists.
|
GB0003960D0
(en)
|
2000-02-18 |
2000-04-12 |
Pfizer Ltd |
Purine derivatives
|
YU79502A
(sh)
|
2000-04-27 |
2006-05-25 |
Boehringer Ingelheim Pharma Gmbh. & Co.Kg. |
Novi,sporodelujući betamimetici,postupak za njihovo pripremanje i njihova primena kao lekova
|
TWI227240B
(en)
|
2000-06-06 |
2005-02-01 |
Pfizer |
2-aminocarbonyl-9H-purine derivatives
|
GB0015727D0
(en)
|
2000-06-27 |
2000-08-16 |
Pfizer Ltd |
Purine derivatives
|
BR0112297A
(pt)
|
2000-06-27 |
2003-05-06 |
S A L V A T Lab Sa |
Compostos carbamatos derivados de arilalquilaminas
|
GB0015876D0
(en)
|
2000-06-28 |
2000-08-23 |
Novartis Ag |
Organic compounds
|
DE10038639A1
(de)
|
2000-07-28 |
2002-02-21 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
AR032361A1
(es)
|
2000-08-05 |
2003-11-05 |
Glaxo Group Ltd |
Derivados de androstano y sales y solvatos de los mismos, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que comprenden tales compuestos, proceso para la preparacion de dichos compuestos, e intermediarios utiles en la preparacion de tales compuestos
|
GB0022695D0
(en)
|
2000-09-15 |
2000-11-01 |
Pfizer Ltd |
Purine Derivatives
|
GB0028383D0
(en)
|
2000-11-21 |
2001-01-03 |
Novartis Ag |
Organic compounds
|
MXPA03005583A
(es)
|
2000-12-22 |
2004-05-05 |
Almirall Prodesfarma Ag |
Derivados de carbamato de quinuclidina y su uso como antagonistas m3.
|
UA75626C2
(en)
|
2000-12-28 |
2006-05-15 |
Almirall Prodesfarma Ag |
Quinuclidine derivatives and medicinal compositions containing the same
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
US7144908B2
(en)
|
2001-03-08 |
2006-12-05 |
Glaxo Group Limited |
Agonists of beta-adrenoceptors
|
EP1241176A1
(en)
|
2001-03-16 |
2002-09-18 |
Pfizer Products Inc. |
Purine derivatives for the treatment of ischemia
|
DE60224172T2
(de)
|
2001-03-22 |
2008-12-04 |
Glaxo Group Ltd., Greenford |
Formanilid-derivative als beta2-adrenorezeptor-agonisten
|
JP4446661B2
(ja)
|
2001-04-30 |
2010-04-07 |
グラクソ グループ リミテッド |
抗炎症性の、17α位に環状エステル基を有するアンドロスタンの17β−カルボチオ酸エステル誘導体
|
US20040171576A1
(en)
|
2001-05-25 |
2004-09-02 |
Michael Yeadon |
Adenosine a2a receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases
|
ATE399174T1
(de)
|
2001-06-12 |
2008-07-15 |
Glaxo Group Ltd |
Neue anti inflammatorische 17.alpha.- heterozyklische ester von 17.beta.-carbothioat androstan derivativen
|
DK2327765T3
(en)
|
2001-06-21 |
2015-07-13 |
Basf Enzymes Llc |
nitrilases
|
NZ531651A
(en)
|
2001-09-14 |
2006-02-24 |
Glaxo Group Ltd |
Phenethanolamine derivatives for treatment of respiratory diseases
|
EP1438309A1
(en)
|
2001-10-17 |
2004-07-21 |
Ucb, S.A. |
Quinuclidine derivatives, processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors
|
GB0125259D0
(en)
|
2001-10-20 |
2001-12-12 |
Glaxo Group Ltd |
Novel compounds
|
MY130622A
(en)
|
2001-11-05 |
2007-07-31 |
Novartis Ag |
Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
|
US6653323B2
(en)
|
2001-11-13 |
2003-11-25 |
Theravance, Inc. |
Aryl aniline β2 adrenergic receptor agonists
|
TWI249515B
(en)
|
2001-11-13 |
2006-02-21 |
Theravance Inc |
Aryl aniline beta2 adrenergic receptor agonists
|
AU2002356759A1
(en)
|
2001-12-01 |
2003-06-17 |
Glaxo Group Limited |
17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
|
EA006505B1
(ru)
|
2001-12-20 |
2005-12-29 |
Лабораториос С.А.Л.В.А.Т.,С.А. |
Производные карбамата 1-алкил-1-азониабицикло[2.2.2]октана и их применение в качестве антагонистов мускаринового рецептора
|
WO2003072592A1
(en)
|
2002-01-15 |
2003-09-04 |
Glaxo Group Limited |
17.alpha-cycloalkyl/cycloylkenyl esters of alkyl-or haloalkyl-androst-4-en-3-on-11.beta.,17.alpha.-diol 17.beta.-carboxylates as anti-inflammatory agents
|
AU2003201693A1
(en)
|
2002-01-21 |
2003-09-02 |
Glaxo Group Limited |
Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
|
GB0202216D0
(en)
|
2002-01-31 |
2002-03-20 |
Glaxo Group Ltd |
Novel compounds
|
GB0204719D0
(en)
|
2002-02-28 |
2002-04-17 |
Glaxo Group Ltd |
Medicinal compounds
|
US6933410B2
(en)
|
2002-03-08 |
2005-08-23 |
Novartis Ag |
Process for preparing 5,6-diethyl-2,3-dihydro-1H-inden-2-amine
|
WO2003082280A1
(en)
|
2002-03-26 |
2003-10-09 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
CA2477764A1
(en)
|
2002-03-26 |
2003-10-09 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
WO2003086408A1
(en)
|
2002-04-10 |
2003-10-23 |
University Of Virginia Patent Foundation |
Use of a2a adenosine receptor agonists for the treatment of inflammatory diseases
|
US7282591B2
(en)
|
2002-04-11 |
2007-10-16 |
Merck & Co., Inc. |
1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
|
ES2206021B1
(es)
|
2002-04-16 |
2005-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de pirrolidinio.
|
WO2003091204A1
(en)
|
2002-04-25 |
2003-11-06 |
Glaxo Group Limited |
Phenethanolamine derivatives
|
JP2005527618A
(ja)
|
2002-05-28 |
2005-09-15 |
セラヴァンス インコーポレーテッド |
アルコキシアリールβ2アドレナリン作動性レセプターアゴニスト
|
ES2201907B1
(es)
|
2002-05-29 |
2005-06-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
DE10224888A1
(de)
|
2002-06-05 |
2003-12-24 |
Merck Patent Gmbh |
Pyridazinderivate
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
DE10225574A1
(de)
|
2002-06-10 |
2003-12-18 |
Merck Patent Gmbh |
Aryloxime
|
DE10227269A1
(de)
|
2002-06-19 |
2004-01-08 |
Merck Patent Gmbh |
Thiazolderivate
|
JP2006502104A
(ja)
|
2002-06-25 |
2006-01-19 |
メルク フロスト カナダ アンド カンパニー |
8−(ビアリール)キノリンpde4阻害剤
|
JP2005538972A
(ja)
|
2002-07-02 |
2005-12-22 |
メルク フロスト カナダ アンド カンパニー |
ジアリール置換エタンピリドンpde4阻害剤
|
ES2204295B1
(es)
|
2002-07-02 |
2005-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de quinuclidina-amida.
|
AU2003281355A1
(en)
|
2002-07-08 |
2004-01-23 |
Pfizer Products Inc. |
Modulators of the glucocorticoid receptor
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
PE20050130A1
(es)
*
|
2002-08-09 |
2005-03-29 |
Novartis Ag |
Compuestos organicos
|
AU2003255376A1
(en)
|
2002-08-10 |
2004-03-11 |
Altana Pharma Ag |
Piperidine-derivatives as pde4 inhibitors
|
PL214701B1
(pl)
|
2002-08-10 |
2013-09-30 |
Nycomed Gmbh |
Pochodna piperydyny, kompozycja farmaceutyczna zawierajaca te pochodna oraz zastosowanie lecznicze tej pochodnej
|
CA2494650A1
(en)
|
2002-08-10 |
2004-03-04 |
Altana Pharma Ag |
Pyridazinone-derivatives as pde4 inhibitors
|
AU2003260371A1
(en)
|
2002-08-10 |
2004-03-11 |
Altana Pharma Ag |
Piperidine-n-oxide-derivatives
|
WO2004018465A2
(en)
|
2002-08-17 |
2004-03-04 |
Altana Pharma Ag |
Benzonaphthyridines with pde 3/4 inhibiting activity
|
WO2004018431A2
(en)
|
2002-08-17 |
2004-03-04 |
Altana Pharma Ag |
Novel phenanthridines
|
SE0202483D0
(sv)
|
2002-08-21 |
2002-08-21 |
Astrazeneca Ab |
Chemical compounds
|
DE60322713D1
(de)
|
2002-08-21 |
2008-09-18 |
Boehringer Ingelheim Pharma |
Substituierte dihydrochinoline als glucocorticoid-mmimetika,verfahren zu deren herstellung, pharmazeutische zubereitungen und deren verwendung
|
CN1688544A
(zh)
|
2002-08-23 |
2005-10-26 |
兰贝克赛实验室有限公司 |
作为蕈毒碱受体拮抗剂的含氟代和磺酰氨基的3,6-二取代的氮杂双环(3.1.0)己烷衍生物
|
ATE348616T1
(de)
|
2002-08-29 |
2007-01-15 |
Altana Pharma Ag |
2-hydroxy-6-phenylphenanthridine als pde-4-hemmer
|
WO2004019935A1
(en)
|
2002-08-29 |
2004-03-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
-3 (sulfonamidoethyl) -indole derivaties for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases
|
JP4587295B2
(ja)
|
2002-08-29 |
2010-11-24 |
ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Pde4インヒビターとしての3−ヒドロキシ−6−フェニルフェナントリジン
|
GB0220730D0
(en)
|
2002-09-06 |
2002-10-16 |
Glaxo Group Ltd |
Medicinal compounds
|
JP2006096662A
(ja)
|
2002-09-18 |
2006-04-13 |
Sumitomo Pharmaceut Co Ltd |
新規6−置換ウラシル誘導体及びアレルギー性疾患の治療剤
|
AU2003272879A1
(en)
|
2002-09-18 |
2004-04-08 |
Ono Pharmaceutical Co., Ltd. |
Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient
|
WO2004026248A2
(en)
|
2002-09-20 |
2004-04-01 |
Merck & Co., Inc. |
Octahydro-2-h-naphtho[1,2-f] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators
|
JP2004107299A
(ja)
|
2002-09-20 |
2004-04-08 |
Japan Energy Corp |
新規1−置換ウラシル誘導体及びアレルギー性疾患の治療剤
|
DE10246374A1
(de)
|
2002-10-04 |
2004-04-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
PL376396A1
(en)
|
2002-10-11 |
2005-12-27 |
Pfizer Inc. |
Indole derivatives as beta-2 agonists
|
EP1440966A1
(en)
|
2003-01-10 |
2004-07-28 |
Pfizer Limited |
Indole derivatives useful for the treatment of diseases
|
AU2003298094A1
(en)
|
2002-10-22 |
2004-05-13 |
Glaxo Group Limited |
Medicinal arylethanolamine compounds
|
ATE380185T1
(de)
|
2002-10-23 |
2007-12-15 |
Glenmark Pharmaceuticals Ltd |
Tricyclische verbindungen zur behandlung von entzündlichen- und allergischen erkrankungen: verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
|
GB0225030D0
(en)
|
2002-10-28 |
2002-12-04 |
Glaxo Group Ltd |
Medicinal compounds
|
US7442839B2
(en)
|
2002-10-28 |
2008-10-28 |
Glaxo Group Limited |
Phenethanolamine derivative for the treatment of respiratory diseases
|
GB0225287D0
(en)
|
2002-10-30 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
GB0225535D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0225540D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
DE10253282A1
(de)
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
|
DE10253426B4
(de)
|
2002-11-15 |
2005-09-22 |
Elbion Ag |
Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung
|
DE10253220A1
(de)
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Dihydroxy-Methyl-Phenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
DE10261874A1
(de)
|
2002-12-20 |
2004-07-08 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
AU2004207482B2
(en)
|
2003-01-21 |
2009-10-08 |
Merck Sharp & Dohme Corp. |
17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators
|
PE20040950A1
(es)
|
2003-02-14 |
2005-01-01 |
Theravance Inc |
DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
|
EP1460064A1
(en)
|
2003-03-14 |
2004-09-22 |
Pfizer Limited |
Indole-2-carboxamide derivatives useful as beta-2 agonists
|
EP1615881A2
(en)
|
2003-04-01 |
2006-01-18 |
Theravance, Inc. |
Diarylmethyl and related compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
|
DE602004019198D1
(de)
|
2003-04-04 |
2009-03-12 |
Novartis Ag |
Chinolin-2-on-derivate zur behandlung von erkankungen der atemwege
|
FR2854185A1
(fr)
*
|
2003-04-26 |
2004-10-29 |
Frederic Brothier |
Procede de pose rapide de panneaux interchangeables structures en feuillets.
|
DE602004024383D1
(de)
*
|
2003-05-08 |
2010-01-14 |
Theravance Inc |
Kristalline formen eines arylanilin-beta-2-adrenergenrezeptor-agonists
|
US7268147B2
(en)
|
2003-05-15 |
2007-09-11 |
Pfizer Inc |
Compounds useful for the treatment of diseases
|
DE602004021921D1
(de)
|
2003-05-28 |
2009-08-20 |
Theravance Inc |
Azabicycloalkanverbindungen als muscarinrezeptor antagonisten
|
DE602004011513T2
(de)
|
2003-06-04 |
2009-01-29 |
Pfizer Inc. |
2-amino-pyridin-derivate als beta-2 adrenoreceptor agonisten
|
GB0312832D0
(en)
|
2003-06-04 |
2003-07-09 |
Pfizer Ltd |
2-amino-pyridine derivatives useful for the treatment of diseases
|
WO2005033121A2
(en)
|
2003-10-03 |
2005-04-14 |
King Pharmaceuticals Research & Development, Inc. |
Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
|
GB0324654D0
(en)
|
2003-10-22 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0324886D0
(en)
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
WO2005080375A1
(en)
*
|
2004-02-13 |
2005-09-01 |
Theravance, Inc. |
Crystalline form of a biphenyl compound
|
CA2565243A1
(en)
|
2004-05-13 |
2005-11-24 |
Boehringer Ingelheim International Gmbh |
Hydroxy-substituted benzo-condensed heterocycles for use as beta agonists in the treatment of respiratory diseases
|
JP2008510015A
(ja)
*
|
2004-08-16 |
2008-04-03 |
セラヴァンス, インコーポレーテッド |
β2アドレナリン作用性レセプターアゴニスト活性およびムスカリン性レセプターアンタゴニスト活性を有する化合物
|
GB0426164D0
(en)
*
|
2004-11-29 |
2004-12-29 |
Novartis Ag |
Organic compounds
|
GB0613154D0
(en)
*
|
2006-06-30 |
2006-08-09 |
Novartis Ag |
Organic Compounds
|